These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 26820556
1. Synthesis, in vitro and in vivo pharmacological evaluation of serotoninergic ligands containing an isonicotinic nucleus. Fiorino F, Ciano A, Magli E, Severino B, Corvino A, Perissutti E, Frecentese F, Di Vaio P, Izzo AA, Capasso R, Massarelli P, Nencini C, Rossi I, Kędzierska E, Orzelska-Gòrka J, Bielenica A, Santagada V, Caliendo G. Eur J Med Chem; 2016 Mar 03; 110():133-50. PubMed ID: 26820556 [Abstract] [Full Text] [Related]
2. New 5-HT1A, 5HT2A and 5HT2C receptor ligands containing a picolinic nucleus: Synthesis, in vitro and in vivo pharmacological evaluation. Fiorino F, Magli E, Kędzierska E, Ciano A, Corvino A, Severino B, Perissutti E, Frecentese F, Di Vaio P, Saccone I, Izzo AA, Capasso R, Massarelli P, Rossi I, Orzelska-Gòrka J, Kotlińska JH, Santagada V, Caliendo G. Bioorg Med Chem; 2017 Oct 15; 25(20):5820-5837. PubMed ID: 28943244 [Abstract] [Full Text] [Related]
3. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation. Fiorino F, Perissutti E, Severino B, Santagada V, Cirillo D, Terracciano S, Massarelli P, Bruni G, Collavoli E, Renner C, Caliendo G. J Med Chem; 2005 Aug 25; 48(17):5495-503. PubMed ID: 16107148 [Abstract] [Full Text] [Related]
4. New 5-HT(1A) receptor ligands containing a N'-cyanoisonicotinamidine nucleus: synthesis and in vitro pharmacological evaluation. Fiorino F, Severino B, De Angelis F, Perissutti E, Magli E, Frecentese F, Esposito A, Massarelli P, Nencini C, Santagada V, Caliendo G. Bioorg Med Chem Lett; 2010 May 01; 20(9):2978-82. PubMed ID: 20347301 [Abstract] [Full Text] [Related]
5. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus. Fiorino F, Severino B, De Angelis F, Perissutti E, Magli E, Frecentese F, Esposito A, Massarelli P, Nencini C, Viti B, Santagada V, Caliendo G. Pharmazie; 2009 Sep 01; 64(9):555-64. PubMed ID: 19827295 [Abstract] [Full Text] [Related]
6. New potent 5-HT(2A) receptor ligands containing an N'-cyanopicolinamidine nucleus: Synthesis and in vitro pharmacological evaluation. Fiorino F, Severino B, Magli E, Perissutti E, Frecentese F, Esposito A, Incisivo GM, Ciano A, Massarelli P, Nencini C, Santagada V, Caliendo G. Eur J Med Chem; 2012 Jan 01; 47(1):520-9. PubMed ID: 22133459 [Abstract] [Full Text] [Related]
7. Synthesis and in vitro pharmacological evaluation of novel 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands. Fiorino F, Magli E, Severino B, Corvino A, Ciano A, Perissutti E, Frecentese F, Massarelli P, Nencini C, Santagada V, Caliendo G. Arch Pharm (Weinheim); 2014 Oct 01; 347(10):698-706. PubMed ID: 25113046 [Abstract] [Full Text] [Related]
9. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part 4. Herold F, Król M, Kleps J, Nowak G. Eur J Med Chem; 2006 Jan 01; 41(1):125-34. PubMed ID: 16263195 [Abstract] [Full Text] [Related]
10. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation. Jurczyk S, Kołaczkowski M, Maryniak E, Zajdel P, Pawłowski M, Tatarczyńska E, Kłodzińska A, Chojnacka-Wójcik E, Bojarski AJ, Charakchieva-Minol S, Duszyńska B, Nowak G, Maciag D. J Med Chem; 2004 May 06; 47(10):2659-66. PubMed ID: 15115407 [Abstract] [Full Text] [Related]
11. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics. Bojarski AJ, Paluchowska MH, Duszyńska B, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E. Bioorg Med Chem; 2005 Mar 15; 13(6):2293-303. PubMed ID: 15727878 [Abstract] [Full Text] [Related]
12. Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation. Zajdel P, Subra G, Bojarski AJ, Duszyńska B, Tatarczyńska E, Nikiforuk A, Chojnacka-Wójcik E, Pawłowski M, Martinez J. Bioorg Med Chem; 2007 Apr 15; 15(8):2907-19. PubMed ID: 17321139 [Abstract] [Full Text] [Related]
13. New 4-[omega-(diarylmethylamino)alkyl]- and 4-[omega-(diarylmethoxy)alkyl]-1-arylpiperazines as selective 5-HT1A/5-HT2A receptor ligands with differentiated in vivo activity. Paluchowska MH, Charakchieva-Minol S, Tatarczyńska E, Kłodzińska A, Stachowicz K, Chojnacka-Wójcik E. Pol J Pharmacol; 2004 Apr 15; 56(6):743-54. PubMed ID: 15662087 [Abstract] [Full Text] [Related]
14. Synthesis, in vitro and in vivo 5-HT1A/5-HT2A serotonin receptor activity of new hybrid 1,2,3,4-tetrahydro-gamma-carbolines with 1-(2-methoxyphenyl)piperazine moiety. Boksa J, Charakchieva-Minol S, Duszyńska B, Bugno R, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E, Bojarski AJ. Pol J Pharmacol; 2003 Apr 15; 55(6):1013-9. PubMed ID: 14730096 [Abstract] [Full Text] [Related]
15. Synthesis and biological investigation of new equatorial (β) stereoisomers of 3-aminotropane arylamides with atypical antipsychotic profile. Stefanowicz J, Słowiński T, Wróbel MZ, Herold F, Gomółka AE, Wesołowska A, Jastrzębska-Więsek M, Partyka A, Andres-Mach M, Czuczwar SJ, Łuszczki JJ, Zagaja M, Siwek A, Nowak G, Żołnierek M, Bączek T, Ulenberg S, Belka M, Turło J. Bioorg Med Chem; 2016 Sep 15; 24(18):3994-4007. PubMed ID: 27377863 [Abstract] [Full Text] [Related]
16. Synthesis of new 1,2,3-benzotriazin-4-one-arylpiperazine derivatives as 5-HT1A serotonin receptor ligands. Caliendo G, Fiorino F, Grieco P, Perissutti E, Santagada V, Severino B, Bruni G, Romeo MR. Bioorg Med Chem; 2000 Mar 15; 8(3):533-8. PubMed ID: 10732969 [Abstract] [Full Text] [Related]
17. Synthesis and in-vitro pharmacological evaluation of new 5-HT1A receptor ligands containing a benzotriazinone nucleus. Fiorino F, Severino B, De Angelis F, Perissutti E, Frecentese F, Massarelli P, Bruni G, Collavoli E, Santagada V, Caliendo G. Arch Pharm (Weinheim); 2008 Jan 15; 341(1):20-7. PubMed ID: 18072244 [Abstract] [Full Text] [Related]
18. Synthesis and 5-HT1A/5-HT2A activity of some butyl analogs in the group of phenylpiperazine alkyl pyrimido[2,1-f]theophyllines. Kołaczkowski M, Zajdel P, Fhid O, Duszyńska B, Tatarczyńska E, Pawłowski M. Pharmacol Rep; 2005 Jan 15; 57(2):229-35. PubMed ID: 15886422 [Abstract] [Full Text] [Related]
19. Synthesis, Docking Studies and Pharmacological Evaluation of Serotoninergic Ligands Containing a 5-Norbornene-2-Carboxamide Nucleus. Sparaco R, Kędzierska E, Kaczor AA, Bielenica A, Magli E, Severino B, Corvino A, Gibuła-Tarłowska E, Kotlińska JH, Andreozzi G, Luciano P, Perissutti E, Frecentese F, Casertano M, Leśniak A, Bujalska-Zadrożny M, Oziębło M, Capasso R, Santagada V, Caliendo G, Fiorino F. Molecules; 2022 Oct 01; 27(19):. PubMed ID: 36235029 [Abstract] [Full Text] [Related]
20. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives. Berardi F, Colabufo NA, Giudice G, Perrone R, Tortorella V, Govoni S, Lucchi L. J Med Chem; 1996 Jan 05; 39(1):176-82. PubMed ID: 8568804 [Abstract] [Full Text] [Related] Page: [Next] [New Search]